Publication Information

{'id': 'https://openalex.org/W2000366629', 'doi': 'https://doi.org/10.1111/j.1440-1681.1996.tb01158.x', 'title': 'IRINOTECAN (CPT‐11): A BRIEF OVERVIEW', 'display_name': 'IRINOTECAN (CPT‐11): A BRIEF OVERVIEW', 'publication_year': 1996, 'publication_date': '1996-11-01', 'ids': {'openalex': 'https://openalex.org/W2000366629', 'doi': 'https://doi.org/10.1111/j.1440-1681.1996.tb01158.x', 'mag': '2000366629', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8911750'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1440-1681.1996.tb01158.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168193669', 'display_name': 'Clinical and Experimental Pharmacology and Physiology', 'issn_l': '0305-1870', 'issn': ['0305-1870', '1440-1681'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5018463878', 'display_name': 'Laurent P. Rivory', 'orcid': 'https://orcid.org/0000-0002-1734-7882'}, 'institutions': [{'id': 'https://openalex.org/I165143802', 'display_name': 'University of Queensland', 'ror': 'https://ror.org/00rqy9422', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I165143802']}, {'id': 'https://openalex.org/I2801814493', 'display_name': 'Princess Alexandra Hospital', 'ror': 'https://ror.org/04mqb0968', 'country_code': 'AU', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801814493']}], 'countries': ['AU'], 'is_corresponding': True, 'raw_author_name': 'Laurent P. Rivory', 'raw_affiliation_strings': ['University of Queensland Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.'], 'affiliations': [{'raw_affiliation_string': 'University of Queensland Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.', 'institution_ids': ['https://openalex.org/I165143802', 'https://openalex.org/I2801814493']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5018463878'], 'corresponding_institution_ids': ['https://openalex.org/I165143802', 'https://openalex.org/I2801814493'], 'apc_list': {'value': 3760, 'currency': 'USD', 'value_usd': 3760, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.193, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 42, 'citation_normalized_percentile': {'value': 0.759327, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '23', 'issue': '10-11', 'first_page': '1000', 'last_page': '1004'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12356', 'display_name': 'Bioactive Compounds and Antitumor Agents', 'score': 0.9909, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10274', 'display_name': 'Synthesis and biological activity', 'score': 0.9644, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.8346287}, {'id': 'https://openalex.org/keywords/sn-38', 'display_name': 'SN-38', 'score': 0.83424926}, {'id': 'https://openalex.org/keywords/active-metabolite', 'display_name': 'Active metabolite', 'score': 0.62849534}], 'concepts': [{'id': 'https://openalex.org/C2780259306', 'wikidata': 'https://www.wikidata.org/wiki/Q412197', 'display_name': 'Irinotecan', 'level': 4, 'score': 0.9683221}, {'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.8346287}, {'id': 'https://openalex.org/C2780508388', 'wikidata': 'https://www.wikidata.org/wiki/Q1750127', 'display_name': 'SN-38', 'level': 5, 'score': 0.83424926}, {'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.8009558}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.63534176}, {'id': 'https://openalex.org/C108215921', 'wikidata': 'https://www.wikidata.org/wiki/Q603741', 'display_name': 'Prodrug', 'level': 2, 'score': 0.6321531}, {'id': 'https://openalex.org/C149151106', 'wikidata': 'https://www.wikidata.org/wiki/Q4677569', 'display_name': 'Active metabolite', 'level': 3, 'score': 0.62849534}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.49760845}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.4150153}, {'id': 'https://openalex.org/C2777477808', 'wikidata': 'https://www.wikidata.org/wiki/Q407595', 'display_name': 'Metabolite', 'level': 2, 'score': 0.4124534}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.2968035}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.24151754}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.19494534}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.19055098}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.189259}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.101732284}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077146', 'descriptor_name': 'Irinotecan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1440-1681.1996.tb01158.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168193669', 'display_name': 'Clinical and Experimental Pharmacology and Physiology', 'issn_l': '0305-1870', 'issn': ['0305-1870', '1440-1681'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8911750', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/6', 'score': 0.74, 'display_name': 'Clean water and sanitation'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 28, 'referenced_works': ['https://openalex.org/W106814647', 'https://openalex.org/W1480716635', 'https://openalex.org/W1502025781', 'https://openalex.org/W1521764325', 'https://openalex.org/W1536538430', 'https://openalex.org/W1541204074', 'https://openalex.org/W1549846058', 'https://openalex.org/W1558058463', 'https://openalex.org/W1586224276', 'https://openalex.org/W1604739675', 'https://openalex.org/W1755629647', 'https://openalex.org/W1975616471', 'https://openalex.org/W2006838800', 'https://openalex.org/W2010682743', 'https://openalex.org/W2011048803', 'https://openalex.org/W2018185888', 'https://openalex.org/W2019867999', 'https://openalex.org/W2074325268', 'https://openalex.org/W2078751203', 'https://openalex.org/W2086179083', 'https://openalex.org/W2098822886', 'https://openalex.org/W2100113089', 'https://openalex.org/W2133295671', 'https://openalex.org/W2159921901', 'https://openalex.org/W2175445951', 'https://openalex.org/W2311628233', 'https://openalex.org/W2317936438', 'https://openalex.org/W2415036661'], 'related_works': ['https://openalex.org/W4225948320', 'https://openalex.org/W3003305233', 'https://openalex.org/W2941541752', 'https://openalex.org/W2550413855', 'https://openalex.org/W2479920407', 'https://openalex.org/W2131063689', 'https://openalex.org/W2091899834', 'https://openalex.org/W2014550324', 'https://openalex.org/W2013571577', 'https://openalex.org/W1940591674'], 'abstract_inverted_index': {'1.': [0], 'Irinotecan': [1, 175], '(also': [2], 'known': [3], 'as': [4, 207], 'CPT-11)': [5], 'is': [6, 72, 81, 97, 103, 140, 151, 162, 201], 'a': [7, 19, 39, 86, 125], 'water': [8], 'soluble,': [9], 'semi-synthetic': [10], 'analogue': [11], 'of': [12, 21, 31, 66, 88, 95, 117, 144, 158, 180, 189, 236], '20(S)camptothecin': [13], '(CPT)': [14], 'with': [15, 26, 199, 203], 'promising': [16], 'activity': [17, 71, 94], 'against': [18], 'range': [20], 'tumour': [22], 'types.': [23], '2.': [24], 'As': [25], 'all': [27], 'other': [28, 181], 'active': [29], 'analogues': [30], 'CPT,': [32], 'irinotecan': [33, 80, 102, 159, 200], 'causes': [34], 'cell': [35], 'toxicity': [36, 228], 'by': [37, 164], 'stabilizing': [38], 'ternary': [40], 'complex': [41], 'between': [42], 'the': [43, 114, 138, 141, 149, 217, 220, 226], 'nuclear': [44], 'enzyme': [45], 'topoisomerase': [46], 'I': [47, 93, 185], '(topo': [48], 'I)': [49], 'and': [50, 79, 101, 121, 127, 176, 186, 212], 'double-stranded': [51], 'DNA.': [52], 'This': [53, 70], 'leads': [54], 'to': [55, 84, 107, 124, 160, 194, 223, 230, 233], 'replication': [56], 'fork-arrest,': [57], 'double': [58], 'DNA': [59], 'strand': [60], 'breaks': [61], 'and,': [62], 'possibly,': [63], 'illegitimate': [64], 'recombination': [65], 'vital': [67], 'genes.': [68], '3.': [69], 'much': [73], 'greater': [74], 'for': [75, 153, 219], 'its': [76], 'metabolite': [77], 'SN-38': [78, 145, 161, 177], 'widely': [82], 'considered': [83], 'be': [85, 192, 224, 231], 'prodrug': [87], 'SN-38.': [89], '4.': [90], 'The': [91, 156], 'anti-topo': [92], 'CPT': [96, 118], 'stereoselective': [98], 'at': [99], 'C-20': [100], 'synthesized': [104], 'from': [105], '20(S)CPT': [106], 'ensure': [108], 'maximal': [109], 'activity.': [110], 'In': [111, 131], 'aqueous': [112], 'solutions,': [113], 'lactone': [115, 139], 'ring': [116], 'undergoes': [119], 'reversible': [120], 'spontaneous': [122], 'hydrolysis': [123], 'ring-opened': [126], 'inactive': [128], 'carboxylate': [129], 'form.': [130], 'patients,': [132], 'it': [133], 'has': [134], 'been': [135], 'shown': [136], 'that': [137], 'predominant': [142], 'form': [143], 'in': [146, 172], 'plasma,': [147], 'whereas': [148], 'opposite': [150], 'true': [152], 'irinotecan.': [154], '5.': [155], 'transformation': [157], 'catalysed': [163], 'carboxylesterases.': [165], 'However,': [166], 'this': [167], 'conversion': [168], 'appears': [169, 229], 'relatively': [170], 'inefficient': [171], 'man.': [173], '6.': [174], 'show': [178], 'evidence': [179], 'metabolic': [182], 'reactions': [183], '(type': [184], 'II),': [187], 'some': [188], 'which': [190], 'could': [191], 'subject': [193], 'pharmacogenetic': [195], 'variability.': [196], '7.': [197], 'Therapy': [198], 'associated': [202], 'unusual': [204], 'toxicities,': [205], 'such': [206], 'an': [208, 234], 'acute': [209], 'cholinergic-like': [210], 'syndrome': [211], 'delayed': [213], 'onset': [214], 'diarrhoea.': [215], 'Although': [216], 'mechanism': [218], 'diarrhoea': [221], 'remains': [222], 'defined,': [225], 'cholinergic': [227], 'due': [232], 'inhibition': [235], 'acetylcholinesterase.': [237]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2000366629', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-12-23T18:09:12.554158', 'created_date': '2016-06-24'}